tykhr
sign in
free sign up
Silverback Therapeutics Inc
Biotechnology
Healthcare
SPRY
97.03 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
17.08
52 week high
17.49
high
17.54
52 week low
10.18
low
16.85
growth
29.77 %
previous Close
16.78
P/E ratio
market cap
1.05 B
div yield
0
usd
Sep 2024
qoq
revenue
2.07 M
313.60 %
net incoming
-19.13 M
-52.83 %
eps
0.00 %
-53.85 %
eps surprise
-33.33 %
net profit margin
-924.95 %
1578.00 %
operating incoming
-21.75 M
-41.77 %
net change in cash
3.03 M
115.64 %
cash on hand
39.66 M
8.28 %
cost of revenue
112 K
522.22 %
top